A new transatlantic collaboration between the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and LifeArc will look to develop an affordable and accessible monoclonal antibody therapeutic for Crimean-Congo Hemorrhagic Fever Virus (CCHFV), which could treat and protect thousands of people globally.

New research from Memorial Sloan Kettering Cancer Center (MSK) identifies a rare cell population responsible for AML persistence and resistance to therapy; sheds new light on early brain development; and investigates how other health conditions can increase cancer risk in midlife. MSK clinical trials also supported the recent approval of the targeted drug larotrectinib by the FDA.

The total economic burden of Alzheimer’s disease and related dementias in the United States will reach $781 billion this year, finds a USC-led research team aiming to provide the most comprehensive accounting yet of dementia's growing economic toll.

The Transdisciplinary Research Areas (TRAs) Modelling and Life and Health at the University of Bonn have presented their €100,000 research prize, entitled “Modelling for Life and Health,” for the second time. The winners—Argelander Professor Ana Ivonne Vazquez-Armendariz and Schlegel Professor Jan Hasenauer—will be using their prize money to study the functions of “scavenger cells” in the lungs at the interface between mathematics and medicine.

The invention is a metamaterial, which is a material engineered to feature new and unusual properties that depend on the material’s physical structure rather than its chemical composition. In this case, the researchers built their metamaterial using a combination of simple plastics and custom-made magnetic composites. Using a magnetic field, the researchers changed the metamaterial’s structure, causing it to expand, move and deform in different directions, all remotely without touching the metamaterial.